logo
Select company
Select metric
$ -10MConsolidated Income
VS
Market
35
Sector
68
Industry
82
History
93
$ 7.48Close
$ 3.86 - $ 41.6 52-Week Range
Ticker Information

Ticker

ACXP

Company Name

ACURX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ACURX PHARMACEUTICALS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ACXP - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -10M
3/31/2025$ -11.87M
12/31/2024$ -14.1M
9/30/2024$ -16.44M
6/30/2024$ -16.73M
3/31/2024$ -16.05M
12/31/2023$ -14.58M
9/30/2023$ -12.72M
6/30/2023$ -13.15M
3/31/2023$ -12.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ACURX PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -4.6M.
  • Over the past 5 years, ACURX PHARMACEUTICALS INC's average Cons. Inc. has been $ -12.84M.
  • The median Cons. Inc. for ACURX PHARMACEUTICALS INC during this period was $ -12.74M
  • ACURX PHARMACEUTICALS INC reached its highest Cons. Inc. over the past 5 years at $ -4.6M.
  • The lowest Cons. Inc. recorded by ACURX PHARMACEUTICALS INC in the same timeframe $ -16.73M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ACXP - Consolidated Income, Last 5 years

$ -16.73M

Minimum

Jun 30, 2024

$ -4.6M

Maximum

Dec 31, 2020

$ -12.84M

Average

$ -12.74M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M